跳至主要内容
临床试验/JPRN-jRCTs042180025
JPRN-jRCTs042180025进行中(未招募)2 期

Clinical study of Patient-Specific Cardiac Support Net for dilated cardiomyopathy - PS-CS

Mutsuga Masato0 个研究点目标入组 3 人开始时间: 2019年1月15日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • 1) Patients who sign the consent form of participating clinical study by their free will
  • 2) Patients whose age are 20 years old or more, and 75 years or less at the time of obtaining informed consent
  • 3) Patients with heart failure symptoms in spite of optimal drug oral treatment for heart failure of more than 3 months
  • 4) Patients whom NYHA classification is III or IV, or level of INTERMACS Profile is 4 to 7
  • 5) Patients with LVEDD more than 60 mm or LVEDDi more than 30 mm/m2 in echocardiography
  • 6) Patients with LVEF less than 35% in echocardiography
  • 7) Patients who have the intention of follow-up examination and observation, and can be admitted to visit the hospital which carries out them

排除标准

  • 1. Patients with excessively enlarged heart. LVEDD is more than 85 mm
  • 2. Patients with extremely low LVEF less than 10%
  • 3. Patients with history of cardiac surgery except pacemaker implantation.
  • 4. Patients who are scheduled for other cardiac surgery
  • 5. Patients with the history or the schedule of CABG
  • 6. Patients with the history or candidate of PCI or trans myocardial laser revascularization within 3 months
  • 7. Patients who are implementing the IABP
  • 8. Patients who are adapted to left ventricular assist devices or scheduled heart transplant
  • 9. Patients with the history or schedule for ICD & CRT within 3 months
  • 10. Patients whose life expectancy 1 year or less
  • 11. Heart failure patients in end stage whose surgery risk is unacceptably high
  • 12. Patients who have developed acute myocardial infarction, unstable angina within 3 months
  • 13. Patients with hypertrophic cardiomyopathy
  • 14. Patient with active infection
  • 15. Patients with severe liver dysfunction whose AST or ALT values are more than 5 times of normal range in their institute.
  • 16. Patients with poor lung function. FEV1 is less than 50%
  • 17. Patients with severe renal failure. Serum creatinine is 3 mg/dL or more or patients with dialysis-dependent
  • 18. Patients with diffuse peripheral vascular disease
  • 19. Patients with history of cerebrovascular disease within 3 months
  • 20. Patients with a high degree of bleeding tendency
  • 21. Patients with blood clotting disorders
  • 22. Patients who refuse blood transfusion
  • 23. Patients with poor prognosis by malignant diseases
  • 24. Patients with severe dementia, drug addiction, alcoholism
  • 25. Patients with severe allergy
  • 26. Pregnant or nursing patients. Patients who do not agree with contraception during the study
  • 27. Patients participating in other studies
  • 28. Patients whom the investigator determine unsuitable for participation

研究者

发起方
Mutsuga Masato

相似试验